Genpharmasec Yönetim

Yönetim kriter kontrolleri 0/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	n/a
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	2.1yrs

Son yönetim güncellemeleri

Recent updates

CEO

Genpharmasec CEO'su yok ya da onlar hakkında elimizde veri yok.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Sohan Chaturvedi	CFO & Whole-Time Director	less than a year	₹1.08m	Veri yok
Rajesh Sadhwani	Non-Executive Non-Independent Director	5.8yrs	Veri yok	13.68% ₹ 199.3m
Sneha Sadhwani	Non-Executive Non-Independent Director	5.8yrs	Veri yok	17.43% ₹ 253.9m
Sachin Aphandkar	Independent Director	1.9yrs	₹8.00k	Veri yok
Siddhesh Shende	Non-Executive Independent Director	2.3yrs	₹8.00k	Veri yok
Mayur Bhatt	Non – Executive Independent Director	1.9yrs	₹8.00k	Veri yok

2.1yrs

Ortalama Görev Süresi

47.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 531592 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 2.1 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.

Genpharmasec Yönetim

Yönetim kriter kontrolleri 0/4

Anahtar bilgiler

Son yönetim güncellemeleri

Genpharmasec Limited, Annual General Meeting, Jul 23, 2024

Genpharmasec Limited Announces Appointment of Hardik Makwana as Company Secretary & Compliance Officer

Genpharmasec Limited Announces Executive Changes

Genpharmasec Limited Announces Resignation of Heta Shah as Company Secretary / Compliance Officer

Genpharmasec Limited, Annual General Meeting, Sep 23, 2023

Genpharmasec Limited, Annual General Meeting, Sep 23, 2023

Recent updates

New minor risk - Share price stability

First quarter 2025 earnings released

Genpharmasec Limited to Report Q1, 2025 Results on Aug 13, 2024

Genpharmasec Limited, Annual General Meeting, Jul 23, 2024

Genpharmasec Limited Announces Appointment of Hardik Makwana as Company Secretary & Compliance Officer

Genpharmasec Limited Announces Executive Changes

Genpharmasec Limited Announces Resignation of Heta Shah as Company Secretary / Compliance Officer

Genpharmasec Limited (BSE:531592) completed the acquisition of an unknown stake in Derren Healthcare Private Limited from the existing shareholder.

Genpharmasec Limited (BSE:531592) completed the acquisition of an unknown stake in Derren Healthcare Private Limited from the existing shareholder.

New major risk - Shareholder dilution

Genpharmasec Limited has completed a Follow-on Equity Offering in the amount of INR 484.504738 million.

Third quarter 2024 earnings released

Genpharmasec Limited to Report Q3, 2024 Results on Feb 12, 2024

New minor risk - Share price stability

Second quarter 2024 earnings released

Genpharmasec Limited (BSE:531592) signed a share purchase agreement to acquire an unknown stake in Derren Healthcare Private Limited from the existing shareholder for approximately INR 130 million.

Genpharmasec Limited (BSE:531592) signed a share purchase agreement to acquire an unknown stake in Derren Healthcare Private Limited from the existing shareholder for approximately INR 130 million.

Genpharmasec Limited, Annual General Meeting, Sep 23, 2023

Genpharmasec Limited, Annual General Meeting, Sep 23, 2023

First quarter 2024 earnings released

Genpharmasec Limited to Report Q1, 2024 Results on Aug 11, 2023

Genpharmasec Limited to Report Q4, 2023 Results on May 26, 2023

Third quarter 2023 earnings released: EPS: ₹0.01 (vs ₹0.01 in 3Q 2022)

Genpharmasec Limited to Report Q3, 2023 Results on Feb 10, 2023

Genpharmasec Limited to Report Q2, 2023 Results on Nov 11, 2022

Genpharmasec Limited Announces Board Changes

Genpharmasec Limited Appoints Heta Shah as Company Secretary and Compliance Officer, with Effect from October 7, 2022

Genpharmasec Limited Announces Resignation of Amisha Mitesh Dani as Independent Director

Genpharmasec Limited, Annual General Meeting, Sep 29, 2022

Genpharmasec Limited, Annual General Meeting, Sep 29, 2022

First quarter 2023 earnings released: ₹0.01 loss per share (vs ₹0.01 profit in 1Q 2022)

Genpharmasec Limited Announces Executive Appointments

Genpharmasec Limited Announces Director Resignations with Effect from June 21, 2022

Genpharmasec Limited Announces Resignation of Independent Directors

Full year 2022 earnings released: ₹0.01 loss per share (vs ₹0.046 profit in FY 2021)

Genpharmasec Limited to Report Q4, 2022 Results on May 27, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Genpharmasec Limited Announces Resignation of Vivek Anand Oberoi as Chief Strategy Officer

High number of new and inexperienced directors

High number of new and inexperienced directors

Additional Non-Executive Independent Director Sachin Aphandkar has left the company

High number of new and inexperienced directors

First quarter 2022 earnings released: EPS ₹0.01

Non Executive Independent Director Veda Bhushan has left the company

Full year 2021 earnings released: EPS ₹0.05 (vs ₹0.047 in FY 2020)

New 90-day low: ₹9.05

Third quarter 2021 earnings released

Generic Pharmasec Limited to Report Q3, 2021 Results on Feb 10, 2021

New 90-day low: ₹9.96

New 90-day low: ₹10.30

New 90-day high: ₹13.09

Generic Pharmasec Limited, Annual General Meeting, Dec 22, 2020

New 90-day low: ₹10.39

First quarter earnings released

Generic Pharmasec Limited to Report Q1, 2021 Results on Sep 07, 2020

CEO

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş